Breaking News

Financial Report: BASi

December 28, 2012

Restructuring charges impacts results


4Q Revenues: $6.5 million (-20%)

4Q Loss: $2.3 million (loss of $668,000 4Q11)

YTD Revenues: $28.2 million (-15%)

YTD Loss: $6.4 million (earnings were $543,000 YTD11)

Comments: Service revenue was down 17% in the quarter to $5.2 million. Product revenue was down 29% to $1.3 million. Restructuring charges were $2.5 million in the quarter and $3.2 million for the year. Revenue decline is attributed to the consolidation of the company's Oregon facility into its West Lafayette facility and the closure of its UK lab.
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision